Yep, it's a catch 22. One thing is certain, the landscape has changed and people's perceptions is now unpredictable.
We are looking at this time next year FDA approval for BTT; it is the immediate focus. And knowing Heartmate II had a strong uptake we should be entitled to expect the same for VCR device.
As bowtie said "we can go the anyone"...that's after FDA approval.
- Forums
- ASX - By Stock
- shorts
VCR
ventracor limited